Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-15

FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approves Ajanta Pharma USA Inc.'s original-application generic combination of omeprazole and sodium bicarbonate for acid-related disorders, expanding access…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole and sodium bicarbonate (omeprazole and sodium bicarbonate)

Snippet

ORIG AP for OMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE AND SODIUM BICARBONATE)